Federated Hermes’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
Other funds holding CAPR
JHC
Federated Hermes's CAPR Position: Q3 2026 in Review
Federated Hermes opened a new position in Capricor Therapeutics (CAPR) in Q3 2026: 19,580 shares worth $185K. The stake represents ﹤0.01% of the portfolio and ranks #1505 among its holdings. This is a return to the name: Federated Hermes previously reported a position in CAPR as recently as Q1 2024.
Federated Hermes first reported a position in CAPR in Q4 2022 and has held it in 3 quarters since. 106 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.
- Federated Hermes held 19,580 shares of Capricor Therapeutics worth $185K as of Q3 2026.
- Capricor Therapeutics was a new Federated Hermes position in Q3 2026.
- Capricor Therapeutics made up ﹤0.01% of Federated Hermes's portfolio in Q3 2026, its #1505 holding.
- Federated Hermes first reported a position in Capricor Therapeutics in Q4 2022 and has held it in 3 quarters since.
- 106 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.
Based on Federated Hermes's 13F filing for Q3 2026, filed 12 Nov 2026.